SAN FRANCISCO, Jan. 7, 2025 /PRNewswire/ — Arbital Health, a healthcare technology and actuarial leader that centralizes, measures, and adjudicates value-based care contracts at scale, is excited to announce the completion of a transaction that will add another team of senior value-based care actuarial professionals to the company. Since the company’s launch in early 2024, Arbital Health has added 30 new clients, successfully launched its value-based care contract adjudication platform, transitioned initial clients to the platform, and adjudicated 250 value-based care contracts. The newly integrated team amplifies Arbital Health’s robust organic growth and expands the company’s ability to deliver technology solutions and specialized expertise in value-based care risk arrangements.
Led by Tim Smith, ASA, MAAA, the five-person team brings decades of experience in actuarial analysis, medical economics, and data science. Their strengths include provider network strategy and analytics, fostering alignment between delivery systems and health plans in value-based care arrangements, and evaluating clinical efficiency and outcomes. As part of this transaction, Tim Smith will be appointed Chief Actuary of Arbital Health, joining the executive management team and strengthening our growing East Coast presence to better serve our customers.
“I am thrilled to welcome Tim and his well-respected team of actuaries to Arbital Health,” said Brian M. Overstreet, President & CEO of Arbital Health. “From our first conversations, it was clear that Tim shared our vision for the future of value-based care and recognized Arbital Health’s unique role in building the critical infrastructure needed to drive the adoption and growth of outcomes-based healthcare nationwide. We believe that solving for incentive misalignment is the biggest challenge in healthcare today. The amazing progress we made in just our first year is proof positive that Arbital Health is primed to play a critical role in unlocking and accelerating the trillion-dollar shift to value-based care. I am especially pleased to welcome Tim to our exceptional management team, and I look forward to working with him to craft our strategy and execution in 2025 and beyond.”
“Along with my team, I am excited to join forces with Arbital Health in what I believe will be a pivotal year for the company and the value-based care industry as a whole,” said Tim Smith, Chief Actuary of Arbital Health. “We’re especially excited to integrate our unique market knowledge and client reach to the Arbital Platform, expanding opportunities for technology and services that enhance contract centralization, measurement, adjudication, and collaboration across the industry.”
About Arbital Health
At Arbital Health we are transforming value-based care, one contract at a time. Our vision is to be the neutral third-party adjudicator of outcomes-based contracts. We centralize, predict, adjudicate, and improve contract performance for healthcare providers, payers, risk enablers, and employers. Through our combination of advanced technology and advisory services, Arbital Health is uniquely positioned to help our clients deliver on their promise of improved patient outcomes while unlocking the trillion-dollar shift to value-based care.
For more information, and to explore career opportunities available, visit ArbitalHealth.com or follow on LinkedIn.
CONTACTS
Media Contact for Arbital Health
Rachel DiMartino
press@arbitalhealth.com
SOURCE Arbital Health
Free to participants in the 2025 survey of PM software, this comprehensive report offers critical…
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - January 8, 2025) - BioHarvest Sciences Inc.,…
Free to participants in the 2025 survey of PM software, this comprehensive report offers critical…
SAN FRANCISCO, CA / ACCESSWIRE / January 8, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) today…
HACKENSACK, NJ / ACCESSWIRE / January 8, 2025 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading…
~ FDA Breakthrough Therapy designation received for PF614-MPAR ~~ PF614-MPAR second clinical trial initiated ~~…